ArticleInternational medical case reports journal2026
An Unlikely Culprit of Hospital-Acquired Warfarin Resistance: A Case Report and Review of Literature.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Warfarin is an anticoagulant medication used to prevent thromboembolic events in many conditions, but therapeutic monitoring requires close attention to prevent serious side effects. Resistance to warfarin can be acquired or hereditary, and many foods and medical conditions have been implicated in acquired warfarin resistance, such as supplemental nutrition shakes in this case presentation. Case Summary: A 65-year-old woman with a prior mechanical aortic valve replacement presented for an elective non-cardiac surgery. She was chronically stable at an international normalized ratio (INR) goal of 2.5-3.5. Surgery was performed without complication, and postoperative INRs were persistently low at 1.5-1.8, despite escalating warfarin doses up to 15 mg warfarin daily at day 12. After a thorough medication and dietary review, the culprit was identified as Boost Plus Nutritional Drinks, a significant source of vitamin K, that she had consumed only while hospitalized postoperatively. Her INR normalized after stopping the shake consumption. Discussion: This is the first known case of a hospitalized patient who developed acquired warfarin resistance from nutritional shakes. Hospitalized patients routinely require supplemental nutrition, and hospitals have a variety of nutritional shakes available, all of which have varying amounts of vitamin K. A review of available supplemental nutrition shakes revealed MightyShakes as the only brand without a significant amount of vitamin K, but other brands also have relatively small quantities of Vitamin K. Conclusion: Supplement administration requires close attention in hospitalized patients on warfarin. Certain brands of nutritional shakes, like MightyShakes, can be safely utilized in such patients if caution is exercised.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.